English
Insider transactions
EDGAROruka Therapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 145 transactions, 4,110,142 shares
- Sum of shares × price per share: 343,710,303.0849
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 274
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,500 | 6.84 | 23,940Derived: shares × price per share. Exact value 23940.00. | 35,271 | Direct (D) | Yes | — | Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,500 | 7.80 | 27,300Derived: shares × price per share. Exact value 27300.00. | 38,771 | Direct (D) | Yes | — | Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,600 | 99.515 | 258,739Derived: shares × price per share. Exact value 258739.000. | 36,171 | Direct (D) | Yes | F1, F2
| Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,500 | 100.4792 | 150,718.8Derived: shares × price per share. Exact value 150718.8000. | 34,671 | Direct (D) | Yes | F1, F3
| Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,900 | 101.5268 | 192,900.92Derived: shares × price per share. Exact value 192900.9200. | 32,771 | Direct (D) | Yes | F1, F4
| Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 300 | 102.47 | 30,741Derived: shares × price per share. Exact value 30741.00. | 32,471 | Direct (D) | Yes | F1, F5
| Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 200 | 103.36 | 20,672Derived: shares × price per share. Exact value 20672.00. | 32,271 | Direct (D) | Yes | F1, F6
| Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 500 | 105.856 | 52,928Derived: shares × price per share. Exact value 52928.000. | 31,771 | Direct (D) | Yes | F1, F7
| Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,500 | 0 | — | 186,563 | Direct (D) | Yes | F8
| Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-16 | Goncalves Joana Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,500 | 0 | — | 157,992 | Direct (D) | Yes | F9
| Open filing 0000907654-26-000118 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 8,542 | 12.5 | 106,775Derived: shares × price per share. Exact value 106775.0. | 22,761 | Direct (D) | Yes | — | Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 1,458 | 34.39 | 50,140.62Derived: shares × price per share. Exact value 50140.62. | 24,219 | Direct (D) | Yes | — | Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 500 | 101.9758 | 50,987.9Derived: shares × price per share. Exact value 50987.9000. | 23,719 | Direct (D) | Yes | F1, F2
| Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 801 | 103.1556 | 82,627.6356Derived: shares × price per share. Exact value 82627.6356. | 22,918 | Direct (D) | Yes | F1, F3
| Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 799 | 104.2502 | 83,295.9098Derived: shares × price per share. Exact value 83295.9098. | 22,119 | Direct (D) | Yes | F1, F4
| Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,842 | 105.2806 | 720,329.8652Derived: shares × price per share. Exact value 720329.8652. | 15,277 | Direct (D) | Yes | F1, F5
| Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 958 | 106.1759 | 101,716.5122Derived: shares × price per share. Exact value 101716.5122. | 14,319 | Direct (D) | Yes | F1, F6
| Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 100 | 107.00 | 10,700Derived: shares × price per share. Exact value 10700.00. | 14,219 | Direct (D) | Yes | F1
| Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 8,542 | 0 | — | 67,834 | Direct (D) | Yes | F7
| Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | Agarwal Arjun Officer: Senior Vice President, Finance | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 1,458 | 0 | — | 55,417 | Direct (D) | Yes | F8
| Open filing 0000907654-26-000116 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | BALL KRISTINE M Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 18,000 | 6.84 | 123,120Derived: shares × price per share. Exact value 123120.00. | 18,000 | Direct (D) | Yes | — | Open filing 0000907654-26-000115 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | BALL KRISTINE M Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,196 | 102.0967 | 122,107.6532Derived: shares × price per share. Exact value 122107.6532. | 16,804 | Direct (D) | Yes | F1, F2
| Open filing 0000907654-26-000115 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | BALL KRISTINE M Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,300 | 103.0932 | 134,021.16Derived: shares × price per share. Exact value 134021.1600. | 15,504 | Direct (D) | Yes | F1, F3
| Open filing 0000907654-26-000115 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | BALL KRISTINE M Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,039 | 104.1622 | 212,386.7258Derived: shares × price per share. Exact value 212386.7258. | 13,465 | Direct (D) | Yes | F1, F4
| Open filing 0000907654-26-000115 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | BALL KRISTINE M Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,765 | 105.3141 | 1,133,706.2865Derived: shares × price per share. Exact value 1133706.2865. | 2,700 | Direct (D) | Yes | F1, F5
| Open filing 0000907654-26-000115 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | BALL KRISTINE M Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,500 | 106.0520 | 265,130Derived: shares × price per share. Exact value 265130.0000. | 200 | Direct (D) | Yes | F1, F6
| Open filing 0000907654-26-000115 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | BALL KRISTINE M Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 200 | 106.9850 | 21,397Derived: shares × price per share. Exact value 21397.0000. | 0 | Direct (D) | Yes | F1, F7
| Open filing 0000907654-26-000115 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-13 | BALL KRISTINE M Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 18,000 | 0 | — | 53,426 | Direct (D) | Yes | F8
| Open filing 0000907654-26-000115 Read from the filing’s XML Dispute this row |
| 2026-11-02 Filed 2026-11-02 | Klein Lawrence Otto Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 25,000 | 7.8 | 195,000Derived: shares × price per share. Exact value 195000.0. | 948,128 | Direct (D) | Yes | — | Open filing 0000907654-26-000112 Read from the filing’s XML Dispute this row |
| 2026-11-02 Filed 2026-11-02 | Klein Lawrence Otto Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,466 | 94.7718 | 612,794.4588Derived: shares × price per share. Exact value 612794.4588. | 941,662 | Direct (D) | Yes | F1, F2
| Open filing 0000907654-26-000112 Read from the filing’s XML Dispute this row |
| 2026-11-02 Filed 2026-11-02 | Klein Lawrence Otto Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 15,036 | 95.6363 | 1,437,987.4068Derived: shares × price per share. Exact value 1437987.4068. | 926,626 | Direct (D) | Yes | F1, F3
| Open filing 0000907654-26-000112 Read from the filing’s XML Dispute this row |
| 2026-11-02 Filed 2026-11-02 | Klein Lawrence Otto Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,442 | 96.7021 | 236,146.5282Derived: shares × price per share. Exact value 236146.5282. | 924,184 | Direct (D) | Yes | F1, F4
| Open filing 0000907654-26-000112 Read from the filing’s XML Dispute this row |
| 2026-11-02 Filed 2026-11-02 | Klein Lawrence Otto Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 756 | 97.4544 | 73,675.5264Derived: shares × price per share. Exact value 73675.5264. | 923,428 | Direct (D) | Yes | F1, F5
| Open filing 0000907654-26-000112 Read from the filing’s XML Dispute this row |
| 2026-11-02 Filed 2026-11-02 | Klein Lawrence Otto Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 300 | 98.4033 | 29,520.99Derived: shares × price per share. Exact value 29520.9900. | 923,128 | Direct (D) | Yes | F1, F6
| Open filing 0000907654-26-000112 Read from the filing’s XML Dispute this row |
| 2026-11-02 Filed 2026-11-02 | Klein Lawrence Otto Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 25,000 | 0 | — | 1,503,513 | Direct (D) | Yes | F7
| Open filing 0000907654-26-000112 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-20 | Quinlan Paul T Officer: General Counsel | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 9,000 | 7.8 | 70,200Derived: shares × price per share. Exact value 70200.0. | 38,995 | Direct (D) | Yes | — | Open filing 0000907654-26-000110 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-20 | Quinlan Paul T Officer: General Counsel | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 400 | 74.9007 | 29,960.28Derived: shares × price per share. Exact value 29960.2800. | 38,595 | Direct (D) | Yes | F1, F2
| Open filing 0000907654-26-000110 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-20 | Quinlan Paul T Officer: General Counsel | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 500 | 76.118 | 38,059Derived: shares × price per share. Exact value 38059.000. | 38,095 | Direct (D) | Yes | F1, F3
| Open filing 0000907654-26-000110 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-20 | Quinlan Paul T Officer: General Counsel | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,000 | 77.205 | 77,205Derived: shares × price per share. Exact value 77205.000. | 37,095 | Direct (D) | Yes | F1, F4
| Open filing 0000907654-26-000110 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-20 | Quinlan Paul T Officer: General Counsel | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,100 | 78.7895 | 323,036.95Derived: shares × price per share. Exact value 323036.9500. | 32,995 | Direct (D) | Yes | F1, F5
| Open filing 0000907654-26-000110 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-20 | Quinlan Paul T Officer: General Counsel | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,000 | 79.4912 | 238,473.6Derived: shares × price per share. Exact value 238473.6000. | 29,995 | Direct (D) | Yes | F1, F6
| Open filing 0000907654-26-000110 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-20 | Quinlan Paul T Officer: General Counsel | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 9,000 | 0 | — | 70,996 | Direct (D) | Yes | F7
| Open filing 0000907654-26-000110 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-15 | Goncalves Joana Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,500 | 6.84 | 23,940Derived: shares × price per share. Exact value 23940.00. | 35,271 | Direct (D) | Yes | — | Open filing 0000907654-26-000108 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-15 | Goncalves Joana Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,500 | 7.80 | 27,300Derived: shares × price per share. Exact value 27300.00. | 38,771 | Direct (D) | Yes | — | Open filing 0000907654-26-000108 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-15 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,853 | 73.8894 | 210,806.4582Derived: shares × price per share. Exact value 210806.4582. | 35,918 | Direct (D) | Yes | F1, F2
| Open filing 0000907654-26-000108 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-15 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,847 | 74.6924 | 137,956.8628Derived: shares × price per share. Exact value 137956.8628. | 34,071 | Direct (D) | Yes | F1, F3
| Open filing 0000907654-26-000108 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-15 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,400 | 75.4834 | 105,676.76Derived: shares × price per share. Exact value 105676.7600. | 32,671 | Direct (D) | Yes | F1, F4
| Open filing 0000907654-26-000108 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-15 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 700 | 76.6652 | 53,665.64Derived: shares × price per share. Exact value 53665.6400. | 31,971 | Direct (D) | Yes | F1, F5
| Open filing 0000907654-26-000108 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-15 | Goncalves Joana Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 200 | 77.71 | 15,542Derived: shares × price per share. Exact value 15542.00. | 31,771 | Direct (D) | Yes | F1, F6
| Open filing 0000907654-26-000108 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-15 | Goncalves Joana Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,500 | 0 | — | 190,063 | Direct (D) | Yes | F7
| Open filing 0000907654-26-000108 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–50 of 273
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| FMR LLC Partly reported under another manager | 10,148,867 SH | 845,299,132 dollars | Higher by 1,091,222 Prior quarter: 9,057,645 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 5,210,214 SH | 433,958,724 dollars | Higher by 220,033 Prior quarter: 4,990,181 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| T. Rowe Price Investment Management, Inc. | 4,392,166 SH | 365,824 dollars | Higher by 3,288,423 Prior quarter: 1,103,743 | Open filing 0001897612-26-000766 Filed 2026-11-16 Dispute this row |
| Venrock Adviser, LLC | 4,148,428 SH | 345,522,568 dollars | Unchanged Prior quarter: 4,148,428 | Open filing 0001615982-26-000019 Filed 2026-11-16 Dispute this row |
| Fairmount Funds Management LLC | 3,705,262 SH | 308,611,272 dollars | Unchanged Prior quarter: 3,705,262 | Open filing 0001104659-26-128188 Filed 2026-11-16 Dispute this row |
| Capital World Investors Partly reported under another manager | 3,429,066 SH | 285,606,907 dollars | Higher by 27,427 Prior quarter: 3,401,639 | Open filing 0001422849-26-000169 Filed 2026-11-12 Dispute this row |
| RTW INVESTMENTS, LP | 3,139,030 SH | 261,449,809 dollars | Unchanged Prior quarter: 3,139,030 | Open filing 0001493215-26-000214 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 2,817,132 SH | 234,617,269 dollars | Higher by 144,042 Prior quarter: 2,673,090 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,644,280 SH | 220,242,081 dollars | Higher by 283,309 Prior quarter: 2,360,971 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| Paradigm Biocapital Advisors LP | 2,493,507 SH | 207,684,198 dollars | Higher by 348,981 Prior quarter: 2,144,526 | Open filing 0001855655-26-000020 Filed 2026-11-16 Dispute this row |
| FRANKLIN TEMPLETON INC Partly reported under another manager | 2,033,669 SH | 206,234,373 dollars | Higher by 412,218 Prior quarter: 1,621,451 | Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row |
| Janus Henderson Group Ltd. Partly reported under another manager | 1,873,153 SH | 155,957,838 dollars | Not in the prior quarter’s filings read | Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row |
| Bellevue Group AG Partly reported under another manager | 1,641,059 SH | 136,683,804 dollars | Lower by 16,131 Prior quarter: 1,657,190 | Open filing 0001104659-26-128575 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,592,427 SH | 132,633,245 dollars | Higher by 1,010,018 Prior quarter: 582,409 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| RA CAPITAL MANAGEMENT, L.P. | 1,554,597 SH | 129,482,384 dollars | Unchanged Prior quarter: 1,554,597 | Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 1,545,458 SH | 128,746,470 dollars | Higher by 115,504 Prior quarter: 1,429,954 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Polar Capital Holdings Plc Partly reported under another manager | 1,224,841 SH | 102,017,007 dollars | Lower by 3,768 Prior quarter: 1,228,609 | Open filing 0001172661-26-005169 Filed 2026-11-16 Dispute this row |
| PERCEPTIVE ADVISORS LLC | 1,072,363 SH | 89,317,114 dollars | Lower by 272,700 Prior quarter: 1,345,063 | Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row |
| Deep Track Capital, LP | 1,069,774 SH | 89,101,476 dollars | Lower by 856,226 Prior quarter: 1,926,000 | Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row |
| PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager | 966,767 SH | 80,523 dollars | Higher by 128,164 Prior quarter: 838,603 | Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row |
| Remedium Capital Partners, LLC Partly reported under another manager | 954,150 SH | 79,471,154 dollars | Lower by 611,511 Prior quarter: 1,565,661 | Open filing 0002104501-26-000021 Filed 2026-11-13 Dispute this row |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 829,749 SH | 69,109,794 dollars | Higher by 198,316 Prior quarter: 631,433 | Open filing 0001177719-26-000022 Filed 2026-11-12 Dispute this row |
| Avidity Partners Management LP | 785,424 SH | 65,417,965 dollars | Higher by 25,000 Prior quarter: 760,424 | Open filing 0001791827-26-000008 Filed 2026-11-16 Dispute this row |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 723,922 SH | 60,295,463 dollars | Higher by 65,621 Prior quarter: 658,301 | Open filing 0001172661-26-005064 Filed 2026-11-16 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 695,630 SH | 57,409,788 dollars | Higher by 40,603 Prior quarter: 655,027 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| Aberdeen Group plc Partly reported under another manager | 632,408 SH | 52,673,262 dollars | Lower by 14,535 Prior quarter: 646,943 | Open filing 0001716774-26-000032 Filed 2026-11-10 Dispute this row |
| Affinity Asset Advisors, LLC | 600,000 SH | 49,974,000 dollars | Higher by 10,000 Prior quarter: 590,000 | Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 582,289 SH | 48,498,851 dollars | Higher by 402,850 Prior quarter: 179,439 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 520,681 SH | 43,367,520 dollars | Higher by 87,276 Prior quarter: 433,405 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager | 459,528 SH | 38,274,087 dollars | Lower by 619,487 Prior quarter: 1,079,015 | Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 446,386 SH | 37,179,490 dollars | Higher by 17,495 Prior quarter: 428,891 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| VOYA INVESTMENT MANAGEMENT LLC Partly reported under another manager | 412,814 SH | 34,383,278 dollars | Higher by 11,665 Prior quarter: 401,149 | Open filing 0001068837-26-000006 Filed 2026-11-10 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 403,555 SH | 33,612,096 dollars | Higher by 37,925 Prior quarter: 365,630 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| Pictet Asset Management Holding SA | 401,928 SH | 33,475,789 dollars | Lower by 217,148 Prior quarter: 619,076 | Open filing 0001993888-26-000007 Filed 2026-11-03 Dispute this row |
| Cormorant Asset Management, LP Partly reported under another manager | 400,000 SH | 33,316,000 dollars | Lower by 133,340 Prior quarter: 533,340 | Open filing 0001583977-26-000011 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 394,246 SH | 32,836,749 dollars | Higher by 39,243 Prior quarter: 355,003 | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| Point72 Asset Management, L.P. | 373,455 SH | 31,105,067 dollars | Not in the prior quarter’s filings read | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Partly reported under another manager | 345,003 SH | 28,735,300 dollars | Lower by 19,099 Prior quarter: 364,102 | Open filing 0000912938-26-001073 Filed 2026-11-12 Dispute this row |
| Candriam S.C.A. | 339,032 SH | 28,341,147 dollars | Lower by 13,684 Prior quarter: 352,716 | Open filing 0001537014-26-000009 Filed 2026-11-03 Dispute this row |
| UBS Group AG Partly reported under another manager | 320,044 SH | 26,656,465 dollars | Lower by 319,319 Prior quarter: 639,363 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| BRAIDWELL LP | 319,679 SH | 26,626,064 dollars | Higher by 41,515 Prior quarter: 278,164 | Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row |
| LORD, ABBETT CO. LLC | 306,236 SH | 25,506 dollars | Lower by 83,828 Prior quarter: 390,064 | Open filing 0000930413-26-003314 Filed 2026-11-13 Dispute this row |
| JENNISON ASSOCIATES LLC Partly reported under another manager | 301,727 SH | 25,130,843 dollars | Higher by 2,470 Prior quarter: 299,257 | Open filing 0000053417-26-000068 Filed 2026-11-16 Dispute this row |
| Ghisallo Capital Management LLC | 300,000 SH | 24,987,000 dollars | Higher by 250,000 Prior quarter: 50,000 | Open filing 0001172661-26-005475 Filed 2026-11-19 Dispute this row |
| MPM BIOIMPACT LLC | 300,000 SH | 24,987,000 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-463462 Filed 2026-11-16 Dispute this row |
| Caption Management, LLC Option: Put | 300,000 SH | 24,987,000 dollars | Not in the prior quarter’s filings read | Open filing 0001706766-26-000008 Filed 2026-11-16 Dispute this row |
| EVENTIDE ASSET MANAGEMENT, LLC | 295,000 SH | 24,570,550 dollars | Higher by 55,000 Prior quarter: 240,000 | Open filing 0001580642-26-007711 Filed 2026-11-13 Dispute this row |
| Holocene Advisors, LP | 291,573 SH | 24,285,115 dollars | Lower by 14,378 Prior quarter: 305,951 | Open filing 0001172661-26-005338 Filed 2026-11-16 Dispute this row |
| Woodline Partners LP | 285,952 SH | 23,816,942 dollars | Higher by 705 Prior quarter: 285,247 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 281,363 SH | 23,434,724 dollars | Lower by 71,461 Prior quarter: 352,824 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Jupiter Topco LLC 1,375,844 SH
- Sixth Street Partners Management Company, L.P. 433,405 SH
- Siren, L.L.C. 250,000 SH
- Sio Capital Management, LLC 177,118 SH
- PFM Health Sciences, LP 158,825 SH
- First Turn Management, LLC 155,343 SH
- ExodusPoint Capital Management, LP 148,212 SH
- Atika Capital Management LLC 100,000 SH
- Alyeska Investment Group, L.P. 87,744 SH
- Trexquant Investment LP 49,616 SH
- Schonfeld Strategic Advisors LLC 34,860 SH
- Freestone Grove Partners LP 22,421 SH
- GLENMEDE TRUST CO NA 22,096 SH
- ADAR1 Capital Management, LLC 20,840 SH
- SG Americas Securities, LLC 14,576 SH
- AXXCESS WEALTH MANAGEMENT, LLC 14,515 SH
- Sound Capital Solutions LLC 13,396 SH
- OPTIMIZE FINANCIAL INC. 13,396 SH
- Brookwood Investment Group LLC 12,990 SH
- Rock Springs Capital Management LP 12,051 SH
- Stonepine Capital Management, LLC 7,500 SH
- Arrowpoint Investment Partners (Singapore) Pte. Ltd. 6,315 SH
- AMERICAN CENTURY COMPANIES INC 4,948 SH
- Ground Swell Capital, LLC 4,320 SH
- Quadrature Capital Ltd 4,290 SH
- Engineers Gate Manager LP 3,680 SH
- Belvedere Trading LLC 3,531 SH
- Gradient Investments LLC 2,868 SH
- COMMONWEALTH EQUITY SERVICES, LLC 2,332 SH
- FOX RUN MANAGEMENT, L.L.C. 2,247 SH
- State of Wyoming 2,242 SH
- NATURAL INVESTMENTS, LLC 2,125 SH
- MERCER GLOBAL ADVISORS INC /ADV 1,077 SH
- Belvedere Trading LLC 800 SH
- Belvedere Trading LLC 800 SH
- Pacer Advisors, Inc. 720 SH
- Optiver Holding B.V. 284 SH
- GROUP ONE TRADING LLC 136 SH
- Aster Capital Management (DIFC) Ltd 105 SH
- GROUP ONE TRADING LLC 100 SH
- Integrated Wealth Concepts LLC 71 SH
- COMPASS FINANCIAL MANAGEMENT LLC 38 SH
- Key Capital Management, INC 24 SH
- Ares Financial Consulting, LLC 7 SH
- NATIONAL BANK OF CANADA /FI/ 5 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| RTW Investments, LP Common Stock, $0.001 par value | 4.7 | 3,139,030.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493215-26-000198 Dispute this row |
| Roderick Wong Common Stock, $0.001 par value | 4.7 | 3,139,030.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493215-26-000198 Dispute this row |
| T. Rowe Price Investment Management, Inc. COMMON STOCK | 6.6 | 4,392,166 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001897612-26-000718 Dispute this row |
| Fairmount Funds Management LLC Common Stock, $0.001 par value per share | 19.47 | 14,553,895.00 | 07/01/2026 Filed 2026-07-01 | SCHEDULE 13D/AAmendment 6 | Open filing 0001104659-26-080010 Dispute this row |
| Fairmount Healthcare Fund II L.P. Common Stock, $0.001 par value per share | 16.03 | 11,980,587.00 | 07/01/2026 Filed 2026-07-01 | SCHEDULE 13D/AAmendment 6 | Open filing 0001104659-26-080010 Dispute this row |
| Fairmount Healthcare Co-Invest III L.P. Common Stock, $0.001 par value per share | 4.03 | 2,573,308.00 | 07/01/2026 Filed 2026-07-01 | SCHEDULE 13D/AAmendment 6 | Open filing 0001104659-26-080010 Dispute this row |
| Harwin Peter Evan Common Stock, $0.001 par value per share | 19.50 | 14,572,917.00 | 07/01/2026 Filed 2026-07-01 | SCHEDULE 13D/AAmendment 6 | Open filing 0001104659-26-080010 Dispute this row |
| Kiselak Tomas Common Stock, $0.001 par value per share | 19.47 | 14,533,895.00 | 07/01/2026 Filed 2026-07-01 | SCHEDULE 13D/AAmendment 6 | Open filing 0001104659-26-080010 Dispute this row |
| VIKING GLOBAL INVESTORS LP Common Stock, $0.001 par value per share | 2.5 | 1,503,478 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| Viking Global Opportunities Parent GP LLC Common Stock, $0.001 par value per share | 2.5 | 1,503,478 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| Viking Global Opportunities GP LLC Common Stock, $0.001 par value per share | 1.5 | 902,087 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| Viking Global Opportunities Portfolio GP LLC Common Stock, $0.001 par value per share | 1.5 | 902,087 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| Viking Global Opportunities Illiquid Investments Sub-Master LP Common Stock, $0.001 par value per share | 1.5 | 902,087 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| Viking Global Opportunities Drawdown GP LLC Common Stock, $0.001 par value per share | 1 | 601,391 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| Viking Global Opportunities Drawdown Portfolio GP LLC Common Stock, $0.001 par value per share | 1 | 601,391 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| Viking Global Opportunities Drawdown (Aggregator) LP Common Stock, $0.001 par value per share | 1 | 601,391 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| HALVORSEN OLE ANDREAS Common Stock, $0.001 par value per share | 2.5 | 1,503,478 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| Shabet Rose Sharon Common Stock, $0.001 par value per share | 2.5 | 1,503,478 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000905148-26-003735 Dispute this row |
| RTW Investments, LP Common Stock, $0.001 par value | 5.2 | 3,139,030.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001493215-26-000153 Dispute this row |
| Roderick Wong Common Stock, $0.001 par value | 5.2 | 3,139,030.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001493215-26-000153 Dispute this row |
| Venrock Healthcare Capital Partners III, L.P. Common Stock, par value $0.001 per share | 7.4 | 4,556,952.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-26-000934 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, par value $0.001 per share | 7.4 | 4,556,952.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-26-000934 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, par value $0.001 per share | 7.4 | 4,556,952.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-26-000934 Dispute this row |
| VHCP Management III, LLC Common Stock, par value $0.001 per share | 7.4 | 4,556,952.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-26-000934 Dispute this row |
| VHCP Management EG, LLC Common Stock, par value $0.001 per share | 7.4 | 4,556,952.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-26-000934 Dispute this row |
| Nimish Shah Common Stock, par value $0.001 per share | 7.4 | 4,556,952.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-26-000934 Dispute this row |
| Bong Y. Koh Common Stock, par value $0.001 per share | 7.4 | 4,556,952.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-26-000934 Dispute this row |
| Capital World Investors Common Stock | 5.6 | 3,401,639.00 | 06/30/2026 Filed 2026-08-12 | SCHEDULE 13G | Open filing 0001422849-26-000148 Dispute this row |
| Fairmount Funds Management LLC Common Stock, $0.001 par value per share | 19.99 | 13,665,080.00 | 04/30/2026 Filed 2026-05-04 | SCHEDULE 13D/AAmendment 5 | Open filing 0001104659-26-055049 Dispute this row |
| Fairmount Healthcare Fund II L.P. Common Stock, $0.001 par value per share | 16.23 | 11,091,772.00 | 04/30/2026 Filed 2026-05-04 | SCHEDULE 13D/AAmendment 5 | Open filing 0001104659-26-055049 Dispute this row |
| Fairmount Healthcare Co-Invest III L.P. Common Stock, $0.001 par value per share | 4.41 | 2,573,308.00 | 04/30/2026 Filed 2026-05-04 | SCHEDULE 13D/AAmendment 5 | Open filing 0001104659-26-055049 Dispute this row |
| Harwin Peter Evan Common Stock, $0.001 par value per share | 19.99 | 13,660,663.00 | 04/30/2026 Filed 2026-05-04 | SCHEDULE 13D/AAmendment 5 | Open filing 0001104659-26-055049 Dispute this row |
| Kiselak Tomas Common Stock, $0.001 par value per share | 19.99 | 13,665,080.00 | 04/30/2026 Filed 2026-05-04 | SCHEDULE 13D/AAmendment 5 | Open filing 0001104659-26-055049 Dispute this row |
| VIKING GLOBAL INVESTORS LP Common Stock, $0.001 par value per share | 5.3 | 2,666,690 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| Viking Global Opportunities Parent GP LLC Common Stock, $0.001 par value per share | 5.3 | 2,666,690 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| Viking Global Opportunities GP LLC Common Stock, $0.001 par value per share | 3.2 | 1,600,014 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| Viking Global Opportunities Portfolio GP LLC Common Stock, $0.001 par value per share | 3.2 | 1,600,014 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| Viking Global Opportunities Illiquid Investments Sub-Master LP Common Stock, $0.001 par value per share | 3.2 | 1,600,014 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| Viking Global Opportunities Drawdown GP LLC Common Stock, $0.001 par value per share | 2.1 | 1,066,676 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| Viking Global Opportunities Drawdown Portfolio GP LLC Common Stock, $0.001 par value per share | 2.1 | 1,066,676 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| Viking Global Opportunities Drawdown (Aggregator) LP Common Stock, $0.001 par value per share | 2.1 | 1,066,676 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| HALVORSEN OLE ANDREAS Common Stock, $0.001 par value per share | 5.3 | 2,666,690 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| Shabet Rose Sharon Common Stock, $0.001 par value per share | 5.3 | 2,666,690 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000905148-26-002436 Dispute this row |
| The Vanguard Group Common Stock | 0 | 0 | 03/13/2026 Filed 2026-03-27 | SCHEDULE 13G/AAmendment 1 | Open filing 0000102909-26-001923 Dispute this row |
| RTW Investments, LP Common Stock, $0.001 par value | 4.3 | 2,058,148.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493215-26-000040 Dispute this row |
| Roderick Wong Common Stock, $0.001 par value | 4.3 | 2,058,148.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493215-26-000040 Dispute this row |
| Deep Track Capital, LP Common stock, $0.001 Par Value | 4.47 | 2,161,510.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-26-000719 Dispute this row |
| Deep Track Biotechnology Master Fund, Ltd. Common stock, $0.001 Par Value | 3.92 | 1,899,455.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-26-000719 Dispute this row |
| David Kroin Common stock, $0.001 Par Value | 4.47 | 2,161,510.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-26-000719 Dispute this row |
| Deep Track Special Opportunities Fund, LP. Common stock, $0.001 Par Value | 0.54 | 262,055.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-26-000719 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,660,713 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 77,800 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.